292
Participants
Start Date
June 30, 2008
Primary Completion Date
October 31, 2009
Study Completion Date
October 31, 2009
Eltrombopag
75 mg, once daily, oral
Placebo
placebo, once daily, oral
GSK Investigational Site, Taipei
GSK Investigational Site, Taipei
GSK Investigational Site, Douliu
GSK Investigational Site, Kaohsiung City
GSK Investigational Site, Brussels
GSK Investigational Site, Buenos Aires
GSK Investigational Site, Edegem
GSK Investigational Site, Ghent
GSK Investigational Site, New York
GSK Investigational Site, Turin
GSK Investigational Site, Valhalla
GSK Investigational Site, Marseille
GSK Investigational Site, Genoa
GSK Investigational Site, Philadelphia
GSK Investigational Site, Milan
GSK Investigational Site, Milan
GSK Investigational Site, Milan
GSK Investigational Site, Washington D.C.
GSK Investigational Site, Baltimore
GSK Investigational Site, Falls Church
GSK Investigational Site, Charlottesville
GSK Investigational Site, Richmond
GSK Investigational Site, Richmond
GSK Investigational Site, Durham
GSK Investigational Site, Madrid
GSK Investigational Site, Madrid
GSK Investigational Site, Charlotte
GSK Investigational Site, Málaga
GSK Investigational Site, Charleston
GSK Investigational Site, Jacksonville
GSK Investigational Site, Oviedo
GSK Investigational Site, Miami
GSK Investigational Site, Miami
GSK Investigational Site, Montpellier
GSK Investigational Site, Padua
GSK Investigational Site, Nashville
GSK Investigational Site, Bologna
GSK Investigational Site, Seville
GSK Investigational Site, Valencia
GSK Investigational Site, Valencia
GSK Investigational Site, Indianapolis
GSK Investigational Site, Valladolid
GSK Investigational Site, Ann Arbor
GSK Investigational Site, Detroit
GSK Investigational Site, Barakaldo
GSK Investigational Site, Lahore
GSK Investigational Site, Lahore
GSK Investigational Site, Chicago
GSK Investigational Site, Clermont Ferrand Cédex 1
GSK Investigational Site, Lyon
GSK Investigational Site, Lyon
GSK Investigational Site, New Orleans
GSK Investigational Site, Bari
GSK Investigational Site, San Giovanni Rotondo (FG)
GSK Investigational Site, Paris
GSK Investigational Site, Dallas
GSK Investigational Site, Paris
GSK Investigational Site, Paris
GSK Investigational Site, Napoli
GSK Investigational Site, Denver
GSK Investigational Site, Avellino
GSK Investigational Site, Scottsdale
GSK Investigational Site, Los Angeles
GSK Investigational Site, Palermo
GSK Investigational Site, San Francisco
GSK Investigational Site, Villejuif
GSK Investigational Site, Portland
GSK Investigational Site, Saint Petersburg
GSK Investigational Site, Smolensk
GSK Investigational Site, Jaipur
GSK Investigational Site, Mumbai
GSK Investigational Site, Samara
GSK Investigational Site, Yekaterinburg
GSK Investigational Site, Birmingham
GSK Investigational Site, Little Rock
GSK Investigational Site, San Diego
GSK Investigational Site, Boston
GSK Investigational Site, Burlington
GSK Investigational Site, Hershey
GSK Investigational Site, Capital Fefderal
GSK Investigational Site, Taoyuan District
GSK Investigational Site, Ciudad Autonoma de Buenos Aires
GSK Investigational Site, Derqui, Pilar
GSK Investigational Site, Rosario
GSK Investigational Site, Calgary
GSK Investigational Site, Ottawa
GSK Investigational Site, Toronto
GSK Investigational Site, Montreal
GSK Investigational Site, Nice
GSK Investigational Site, Mumbai
GSK Investigational Site, Rome
GSK Investigational Site, Rome
GSK Investigational Site, Chorzów
GSK Investigational Site, Lubin
GSK Investigational Site, Słupsk
GSK Investigational Site, Warsaw
GSK Investigational Site, Wroclaw
GSK Investigational Site, Busan
GSK Investigational Site, Incheon
GSK Investigational Site, Seoul
GSK Investigational Site, Seoul
GSK Investigational Site, Seoul
GSK Investigational Site, Barcelona
GSK Investigational Site, Barcelona
GSK Investigational Site, Barcelona
GSK Investigational Site, Barcelona
GSK Investigational Site, L'Hospitalet de Llobregat
Lead Sponsor
GlaxoSmithKline
INDUSTRY